Saeid Moghassemi

Dr. Saeid Moghassemi

Université Catholique de Louvain, Louvain-la-Neuve, Wallonia, Belgium
orcid
Postdoctoral Researcher, Biomedical and Pharmaceutical Scien...

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Journal of Controlled Release
Verified
Journal Article
Closed access
Saeid MoghassemiSaeid Moghassemi
Saeid Moghassemi
AHAfra Hadjizadeh
Afra Hadjizadeh

19 April 2022 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
VMVijay Sagar Madamsetty
Vijay Sagar Madamsetty
RMReza Mohammadinejad
Reza Mohammadinejad
IUIlona Uzieliene
Ilona Uzieliene
NNNoushin Nabavi
Noushin Nabavi
ADAli Dehshahri
Ali Dehshahri
ASAli Seyfoddin
Ali Seyfoddin

1 July 2019 in Journal of Advanced Research
Verified
Journal Article
Open access
RMReza Mohammadinejad
Reza Mohammadinejad
ADArezoo Dadashzadeh
Arezoo Dadashzadeh
Saeid MoghassemiSaeid Moghassemi
Saeid Moghassemi
MAMilad Ashrafizadeh
Milad Ashrafizadeh
ADAli Dehshahri
Ali Dehshahri
AMAli Mandegary
Ali Mandegary
Recently, carbon dots (CDs) have attracted great attention due to their superior properties, such as biocompatibility, fluorescence, high quantum yield, and uniform distribution. These characteristics make CDs interesting for bioimaging, therapeutic delivery, optogenetics, and theranostics. Photoluminescence (PL) properties enable CDs to act as imaging-trackable gene nanocarriers, while cationic CDs with high transfection efficiency have been applied for plasmid DNA and siRNA delivery. In this review, we have highlighted the precursors, structure and properties of positively charged CDs to demonstrate the various applications of these materials for nucleic acid delivery. Additionally, the potential of CDs as trackable gene delivery systems has been discussed. Although there are several reports on cellular and animal approaches to investigating the potential clinical applications of these nanomaterials, further systematic multidisciplinary approaches are required to examine the pharmacokinetic and biodistribution patterns of CDs for potential clinical applications.

1 January 2015 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
Saeid MoghassemiSaeid Moghassemi
Saeid Moghassemi
EPEhsan Parnian
Ehsan Parnian
AHAmirhossien Hakamivala
Amirhossien Hakamivala
MDMaedeh Darzianiazizi
Maedeh Darzianiazizi
MVMarzieh Mowlavi Vardanjani
Marzieh Mowlavi Vardanjani
KOKobra Omidfar
Kobra Omidfar

1 November 2021 in Journal of Controlled Release
Verified
Journal Article
Closed access
Saeid MoghassemiSaeid Moghassemi
Saeid Moghassemi
ADArezoo Dadashzadeh
Arezoo Dadashzadeh
RARicardo Bentes Azevedo
Ricardo Bentes Azevedo
OFOlivier Feron
Olivier Feron
CAChristiani Amorim
Christiani Amorim

1 June 2024 in Bioactive Materials
Verified
Journal Article
Open access
Saeid MoghassemiSaeid Moghassemi
Saeid Moghassemi
ADArezoo Dadashzadeh
Arezoo Dadashzadeh
MSMaria João Sousa
Maria João Sousa
HVHanne Vlieghe
Hanne Vlieghe
JYJie Yang
Jie Yang
CAChristiani Amorim
Christiani Amorim
Small extracellular vesicles (sEVs) are known to be secreted by a vast majority of cells. These sEVs, specifically exosomes, induce specific cell-to-cell interactions and can activate signaling pathways in recipient cells through fusion or interaction. These nanovesicles possess several desirable properties, making them ideal for regenerative medicine and nanomedicine applications. These properties include exceptional stability, biocompatibility, wide biodistribution, and minimal immunogenicity. However, the practical utilization of sEVs, particularly in clinical settings and at a large scale, is hindered by the expensive procedures required for their isolation, limited circulation lifetime, and suboptimal targeting capacity. Despite these challenges, sEVs have demonstrated a remarkable ability to accommodate various cargoes and have found extensive applications in the biomedical sciences. To overcome the limitations of sEVs and broaden their potential applications, researchers should strive to deepen their understanding of current isolation, loading, and characterization techniques. Additionally, acquiring fundamental knowledge about sEVs origins and employing state-of-the-art methodologies in nanomedicine and regenerative medicine can expand the sEVs research scope. This review provides a comprehensive overview of state-of-the-art exosome-based strategies in diverse nanomedicine domains, encompassing cancer therapy, immunotherapy, and biomarker applications. Furthermore, we emphasize the immense potential of exosomes in regenerative medicine.